This Article Full Text Full Text (PDF) All Versions of this Article: 106/11/1379    most recent 01.CIR.0000028588.73765.B4v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yen, M. H. Articles by Penn, M. S. Search for Related Content PubMed PubMed Citation Articles by Yen, M. H. Articles by Penn, M. S. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Coronary Artery Disease Heart Transplantation Related Collections Pathophysiology Transplantation Coagulation and fibronolysis

(Circulation. 2002;106:1379.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Increased Tissue Factor Expression Predicts Development of Cardiac Allograft Vasculopathy

Michael H. Yen, MD; Guy Pilkington, MS; Randall C. Starling, MD, MPH; Norman B. Ratliff, MD; Patrick M. McCarthy, MD; James B. Young, MD; Guy M. Chisolm, PhD; Marc S. Penn, MD, PhD

From the Department of Cardiovascular Medicine (M.H.Y., R.C.S., J.B.Y., M.S.P.), Department of Cardiothoracic Surgery (P.M.M.), Department of Cell Biology (G.P., G.M.C., M.S.P.), Department of Pathology (N.B.R.), and The Kaufman Center for Heart Failure (R.C.S., P.M.M., J.B.Y.), Cleveland Clinic Foundation, Cleveland, Ohio.

Correspondence to Marc S. Penn, MD, PhD, Departments of Cardiovascular Medicine and Cell Biology, Cleveland Clinic Foundation, NC10, 9500 Euclid Ave, Cleveland, OH 44195. E-mail pennm@ ccf.org

Background— Cardiac allograft vasculopathy (CAV) limits the long-term success of cardiac transplantation. The incidence of CAV is increased in patients with elevated plasma levels of oxidized lipids or fibrin deposition within right heart biopsy (RHB) specimens. The present study investigated whether tissue factor (TF), the expression of which is regulated by oxidized lipids, is upregulated in patients with CAV.

Methods and Results— A TF score was developed to quantify TF expression in RHB specimens from 63 consecutive patients undergoing routine annual posttransplantation RHB and coronary angiography. In patients >2 years (3.0±0.8 years) posttransplantation (n=35), a high TF score was observed with greater frequency (75% versus 26%, P<0.004) in patients with CAV than those without CAV. In patients <2 years (0.87±0.48 years) posttransplantation (n=28) without evidence of CAV, the TF score was determined and patients were followed up prospectively. A high TF score had a positive predictive value of 78.6% for the development of CAV, and a low TF score had a negative predictive value of 100%.

Conclusions— These data demonstrate that early TF expression predicts subsequent development of CAV. Increased TF expression could link the elevated levels of oxidized LDL and fibrin deposition known to precede CAV. These findings suggest that TF may play a role in the pathophysiology of CAV and could offer a potential prognostic tool and a novel target for the prevention of CAV, possibly with antioxidants or inhibitors of the TF pathway.

Key Words: lipoproteins • thrombosis • transplantation • atherosclerosis

This article has been cited by other articles:

				B. Wootla, A. Nicoletti, N. Patey, J. D. Dimitrov, C. Legendre, O. D. Christophe, A. Friboulet, S. V. Kaveri, S. Lacroix-Desmazes, and O. Thaunat Hydrolysis of Coagulation Factors by Circulating IgG Is Associated with a Reduced Risk for Chronic Allograft Nephropathy in Renal Transplanted Patients J. Immunol., June 15, 2008; 180(12): 8455 - 8460. [Abstract] [Full Text] [PDF]

				L. Anderson Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol., February 15, 2005; 563(1): 23 - 60. [Abstract] [Full Text] [PDF]